First Trust Advisors
KYMR icon

First Trust Advisors’s Kymera Therapeutics KYMR Stock Holding History

First Trust Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Sell
61,368
-32,249
-34% -$2.77M ﹤0.01% 1383
2026
Q1 		$7.8M Buy
93,617
+34,755
+59% +$2.75M 0.01% 1220
2025
Q4 		$4.58M Sell
58,862
-15,990
-21% -$1.08M ﹤0.01% 1456
2025
Q3 		$4.24M Buy
+74,852
New +$3.38M ﹤0.01% 1460
2025
Q2 		– Sell
-93,795
Closed -$2.57M – 2657
2025
Q1 		$2.57M Sell
93,795
-82,425
-47% -$3M ﹤0.01% 1670
2024
Q4 		$7.09M Buy
176,220
+53,175
+43% +$2.4M 0.01% 1191
2024
Q3 		$5.82M Sell
123,045
-15,591
-11% -$688K 0.01% 1254
2024
Q2 		$4.14M Buy
138,636
+70,894
+105% +$2.45M ﹤0.01% 1358
2024
Q1 		$2.72M Buy
+67,742
New +$2.42M ﹤0.01% 1598
2023
Q3 		– Sell
-26,591
Closed -$611K – 2441
2023
Q2 		$611K Buy
+26,591
New +$762K ﹤0.01% 2096
2022
Q3 		– Sell
-30,055
Closed -$592K – 2548
2022
Q2 		$592K Sell
30,055
-24,654
-45% -$576K ﹤0.01% 2152
2022
Q1 		$2.31M Sell
54,709
-38,887
-42% -$1.64M ﹤0.01% 1727
2021
Q4 		$5.94M Buy
+93,596
New +$5.45M 0.01% 1281

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

First Trust Advisors's KYMR Position: Q2 2026 in Review

First Trust Advisors reduced its Kymera Therapeutics (KYMR) stake by 34% in Q2 2026, selling an estimated $2.77M and leaving 61,368 shares worth $7.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

First Trust Advisors first reported a position in KYMR in Q4 2021 and has held it in 13 quarters since. The position peaked at $7.8M in Q1 2026. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • First Trust Advisors held 61,368 shares of Kymera Therapeutics worth $7.04M as of Q2 2026.
  • First Trust Advisors sold 32,249 Kymera Therapeutics shares in Q2 2026, an estimated $2.77M.
  • Kymera Therapeutics made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1383 holding.
  • First Trust Advisors first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • First Trust Advisors's Kymera Therapeutics position peaked at $7.8M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.